Where Will Exxon Stock Be in 5 Years?
For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…
Sell
18
GOCO Quote, Financials, Valuation and Earnings
Last price:
$6.00
Seasonality move
:
-33.15%
Day range:
$5.75 - $6.22
52-week range:
$5.40 - $21.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.08x
P/B ratio:
0.28x
Volume:
44K
Avg. volume:
61.6K
1-year change:
-37.82%
Market cap:
$68.4M
Revenue:
$798.9M
EPS (TTM):
-$1.20
Analysts' Opinion
-
Consensus RatingGoHealth has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $21.60, GoHealth has an estimated upside of 251.22% from its current price of $6.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $6.15.
Fair Value
-
According to the consensus of 5 analysts, GoHealth has 251.22% upside to fair value with a price target of $21.60 per share.
GOCO vs. S&P 500
-
Over the past 5 trading days, GoHealth has overperformed the S&P 500 by 9.97% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
GoHealth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GoHealth has grown year-over-year revenues for 2 quarters straight. In the most recent quarter GoHealth reported revenues of $221M.
Earnings Growth
-
GoHealth has grown year-over-year earnings for 0 quarters straight. In the most recent quarter GoHealth reported earnings per share of -$0.52.
Enterprise value:
741.5M
EV / Invested capital:
0.79x
Price / LTM sales:
0.08x
EV / EBIT:
9.44x
EV / Revenue:
0.89x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.62x
Price / Operating cash flow:
9.63x
Enterprise value / EBITDA:
4.02x
Gross Profit (TTM):
$702.4M
Return On Assets:
0.14%
Net Income Margin (TTM):
0.23%
Return On Equity:
0.44%
Return On Invested Capital:
0.21%
Operating Margin:
3.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $544.2M | $737.1M | $834.3M | $185.6M | $221M | |
| Gross Profit | $379M | $585.6M | $702.4M | $147.6M | $181.7M | |
| Operating Income | -$263.7M | -$67.3M | $4.4M | -$4M | $7.4M | |
| EBITDA | -$191.6M | $26.3M | $184.7M | $22.8M | $33.7M | |
| Diluted EPS | -$16.81 | -$7.07 | -$1.20 | -$1.04 | -$0.52 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $320.8M | $391.8M | $375.5M | $397.1M | $260.9M | |
| Total Assets | $2.1B | $2B | $1.5B | $1.4B | $1.4B | |
| Current Liabilities | $99.6M | $140.9M | $209.8M | $300M | $233.4M | |
| Total Liabilities | $701.4M | $1.1B | $970.9M | $959.4M | $931.1M | |
| Total Equity | $1.4B | $860M | $572.6M | $435.8M | $451M | |
| Total Debt | $400.2M | $667.9M | $509.5M | $485.3M | $485.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $26.9M | $101.2M | -$46.5M | $12.5M | -$12.4M | |
| Cash From Investing | -$9.7M | -$16.1M | $5.3M | -$4.6M | -$3M | |
| Cash From Financing | -$114.3M | -$19.7M | -$34.3M | -$942K | -$3.2M | |
| Free Cash Flow | $17.2M | $85.1M | -$58.7M | $8M | -$15.5M | |
GOCO
Sector
Market Cap
$68.4M
$612.8M
Price % of 52-Week High
29.29%
87.27%
Dividend Yield
0%
2.03%
Shareholder Yield
2.9%
4.12%
1-Year Price Total Return
-37.82%
10.97%
Beta (5-Year)
--
0.595
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.84
200-day SMA
Sell
Level
$11.50
Bollinger Bands (100)
Sell
Level
8.26 - 16.14
Chaikin Money Flow
Sell
Level
-7.9M
20-day SMA
Sell
Level
$6.49
Relative Strength Index (RSI14)
Sell
Level
37.60
ADX Line
Sell
Level
38.34
Williams %R
Neutral
Level
-54.2543
50-day SMA
Sell
Level
$8.83
MACD (12, 26)
Sell
Level
-0.93
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Sell
Level
-7.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4504)
Sell
CA Score
(Annual)
Level (-1.4628)
Buy
Beneish M-Score
(Annual)
Level (-2.4599)
Sell
Momentum Score
Level (6)
Sell
Ohlson Score
Level (12.2235)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs.
Stock Forecast FAQ
In the current month, GOCO has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GOCO average analyst price target in the past 3 months is $21.60.
-
Where Will GoHealth Stock Be In 1 Year?
According to analysts, the consensus estimate is that GoHealth share price will rise to $21.60 per share over the next 12 months.
-
What Do Analysts Say About GoHealth?
Analysts are divided on their view about GoHealth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GoHealth is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is GoHealth's Price Target?
The price target for GoHealth over the next 1-year time period is forecast to be $21.60 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is GOCO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GoHealth is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GOCO?
You can purchase shares of GoHealth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GoHealth shares.
-
What Is The GoHealth Share Price Today?
GoHealth was last trading at $6.00 per share. This represents the most recent stock quote for GoHealth. Yesterday, GoHealth closed at $6.15 per share.
-
How To Buy GoHealth Stock Online?
In order to purchase GoHealth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Dollar General Stock Go?
Shares of Dollar General (NYSE:DG) have risen significantly in recent…
How High Can Planet Labs Go Now?
Planet Labs (NYSE:PL) has been a much-talked-about stock for years,…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 34x
Alerts
Sell
19
LULU alert for Jun 9
Lululemon Athletica [LULU] is down 2.36% over the past day.
Sell
46
DOCU alert for Jun 9
Docusign [DOCU] is up 4.37% over the past day.
Sell
15
BRZE alert for Jun 9
Braze [BRZE] is up 3.06% over the past day.
